Overview

Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

Summary

This study is a visual assessment of diagnostic PET/CT images obtained after a single intravenous injection of BAY85-8050 in patients with cancer

Phase:

Phase 1

Details

Lead Sponsor:

Bayer